BAxSIC Study

At long last we have launched BAxSIC (British Axial Spondyloarthritis Inception Cohort) in collaboration with the National Axial Spondyloarthritis Society (NASS).  This aims to provide real-world data to evaluate the impact of delay in diagnosis (from symptom onset to diagnosis) on work participation and functional outcomes and the natural history and impact of newly-diagnosed axial Spondyloarthritis, including disease activity, pain, fatigue, functional and work outcomes, comorbidities, therapies in the UK. The study is a prospective cohort enrolling patients attending rheumatology clinics in the UK who are newly diagnosed with axial Spondyloarthritis and naïve to biologic therapy. The study will run for an initial 3-year period, starting at Leeds in January.  Study inbox is baxsic.ltht@nhs.net.  Visit the BAxSIC Study Website